|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Depreciation, amortization and accretion, net | |||||
| Deferred income tax expense (benefit) | |||||
| Share-based compensation | |||||
| Net realized investment (gains) losses | |||||
| Net trading (gains) losses | |||||
| Loss from equity method investments | |||||
| Impairments and provision for loan and credit losses | |||||
| Net (gains) losses of consolidated investment entities | |||||
| Changes in operating assets and liabilities | |||||
| Restricted and segregated investments | |||||
| Deferred acquisition costs | |||||
| Policyholder account balances, future policy benefits and claims, and market risk benefits, net | |||||
| Derivatives, net of collateral | |||||
| Receivables | |||||
| Brokerage deposits | |||||
| Accounts payable and accrued expenses | |||||
| Current income tax, net | |||||
| Other operating assets and liabilities of consolidated investment entities, net | |||||
| Other, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Available-for-Sale securities: | |||||
| Proceeds from sales | |||||
| Maturities, sinking fund payments and calls | |||||
| Purchases | |||||
| Proceeds from sales, maturities and repayments of mortgage loans | |||||
| Funding of mortgage loans | |||||
| Proceeds from sales, maturities and collections of other investments | |||||
| Purchase of other investments | |||||
| Purchase of investments by consolidated investment entities | |||||
| Proceeds from sales, maturities and repayments of investments by consolidated investment entities | |||||
| Purchase of land, buildings, equipment and software | |||||
| Cash paid for written options with deferred premiums | |||||
| Cash received from written options with deferred premiums | |||||
| Cash returned (paid) for acquisition of business, net of cash acquired | |||||
| Cash paid for deposit receivables | |||||
| Cash received for deposit receivables | |||||
| Other, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Investment certificates: | |||||
| Proceeds from additions | |||||
| Maturities, withdrawals and cash surrenders | |||||
| Policyholder account balances: | |||||
| Deposits and other additions | |||||
| Net transfers from (to) separate accounts | |||||
| Surrenders and other benefits | |||||
| Change in banking deposits, net | |||||
| Cash paid for purchased options with deferred premiums | |||||
| Cash received for purchased options with deferred premiums | |||||
| Issuance of long-term debt, net of issuance costs | |||||
| Repayments of long-term debt | |||||
| Dividends paid to shareholders | |||||
| Repurchase of common shares | |||||
| Exercise of stock options | |||||
| Borrowings of consolidated investment entities | |||||
| Repayments of debt by consolidated investment entities | |||||
| Other, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents, including amounts restricted | |||||
| Cash and cash equivalents, including amounts restricted at beginning of period | |||||
| Cash and cash equivalents, including amounts restricted at end of period | |||||
| Supplemental Disclosures: | |||||
| Interest paid excluding consolidated investment entities | |||||
| Interest paid by consolidated investment entities | |||||
| Ameriprise Financial | |||||
| Consolidated investment entities | |||||
| Income taxes paid, net | |||||
| Leased assets obtained in exchange for finance lease liabilities | |||||
| Leased assets obtained in exchange for operating lease liabilities | |||||
| Investments transferred in connection with fixed annuity reinsurance transaction | |||||
| Exchange of an investment that resulted in a realized gain and an increase to amortized cost | |||||
| Reconciliation of cash and cash equivalents, including amounts restricted: | |||||
| Cash and cash equivalents | |||||
| Ameriprise Financial | |||||
| Consolidated investment entities | |||||
| Restricted and segregated cash, cash equivalents and investments | |||||
| Less: Restricted and segregated investments | |||||
Loading...